| abstract |
Pharmaceutical compositions for topical administration, comprising non-glycosylated erythropoietin (EPO), such as bacterially produced recombinant EPO, are described. The compositions are suitable for use in treatment of a human being or an animal suffering from a disease, disorder or surgical lesion that is alleviated or cured by topical administration of erythropoietin, e.g. a disease or disorder selected from a conjunctivitis, a wound, a bedsore, a burn, an inflammation of the skin, mucous membranes, airways or lungs, an eczema or a skin disorder accompanied by necrosis, by dermatitis, by psoriasis or by diabetes mellitus. The pharmaceutical composition may be in the form of an ointment, a cream, a powder, an emulsion, a gel, a glycerogelatine, a paste, a plaster, a sprayable composition or a lotion. |